{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T13:51:41.912201+00:00","published_at":"2026-10-16T13:51:41.912201+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:published_fact:5","stance":"supports"},{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:security_listing:11","stance":"supports"}],"claim_ids":["alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:legal_name:1","alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:entity_status:3","alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:published_fact:4","alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:published_fact:5","alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:security_listing:11"]},{"evidence_id":"alpha:projection-evidence:document:5dffd2c2610c166b260bac13113faa44af6f6529f1534a4b0cbcc3fc20eac5fc","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000015/nbix-20260415.htm","title":"Neurocrine Biosciences DEF 14A 2026-04-15","identifier":null,"locator":null,"source_date":"2026-04-15","retrieved_at":"2026-07-12T04:22:07.189599+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:6","stance":"supports"},{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:7","stance":"supports"}],"claim_ids":["alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:6","alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:7"]},{"evidence_id":"alpha:projection-evidence:document:bc1c0c8597fdff1a389c6903401eb29f3c3cb5809ad992a2d47c31c3f64128de","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","title":"NBIX 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:25.738673+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:8","stance":"supports"}],"claim_ids":["alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:8"]},{"evidence_id":"alpha:projection-evidence:document:08045820d08e0f27b7dcebc1c1632a91587349bf4d19fc15d2dff5066d4e04e0","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","title":"NBIX 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:24.63779+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:9","stance":"supports"}],"claim_ids":["alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:9"]},{"evidence_id":"alpha:projection-evidence:document:06787e97408e22bd64b79ec078f7c86910f8d149f37f188293c48e7e0da28c06","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","title":"NBIX 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:25.183687+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:10","stance":"supports"}],"claim_ids":["alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:10"]}]},"claims":[{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:legal_name:1","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"NEUROCRINE BIOSCIENCES INC","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"NEUROCRINE BIOSCIENCES INC","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:entity_status:3","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:published_fact:4","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:published_fact:5","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:6","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gary-a-lyons","object_label":"Gary A. Lyons","object_source_name_forms":[],"value":"Gary A. Lyons: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gary-a-lyons","name":"Gary A. Lyons"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1993-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1993-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:document:5dffd2c2610c166b260bac13113faa44af6f6529f1534a4b0cbcc3fc20eac5fc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neurocrine Biosciences DEF 14A 2026-04-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000015/nbix-20260415.htm","source_date":"2026-04-15","retrieved_at":"2026-07-12T04:22:07.189599+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-15","effective_from":"1993-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:7","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:johanna-mercier-gild","object_label":"Johanna Mercier","object_source_name_forms":[],"value":"Johanna Mercier: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:johanna-mercier-gild","name":"Johanna Mercier"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:document:5dffd2c2610c166b260bac13113faa44af6f6529f1534a4b0cbcc3fc20eac5fc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neurocrine Biosciences DEF 14A 2026-04-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000015/nbix-20260415.htm","source_date":"2026-04-15","retrieved_at":"2026-07-12T04:22:07.189599+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-15","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:8","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jude-onyia","object_label":"Jude Onyia","object_source_name_forms":[],"value":"Jude Onyia: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jude-onyia","name":"Jude Onyia"},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:document:bc1c0c8597fdff1a389c6903401eb29f3c3cb5809ad992a2d47c31c3f64128de","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NBIX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:25.738673+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:9","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:kyle-w-gano","object_label":"Kyle W. Gano","object_source_name_forms":[],"value":"Kyle W. Gano: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:kyle-w-gano","name":"Kyle W. Gano"},"title":"Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:document:08045820d08e0f27b7dcebc1c1632a91587349bf4d19fc15d2dff5066d4e04e0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NBIX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:24.63779+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:leadership_role:10","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:matthew-c-abernethy","object_label":"Matthew C. Abernethy","object_source_name_forms":[],"value":"Matthew C. Abernethy: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:matthew-c-abernethy","name":"Matthew C. Abernethy"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:document:06787e97408e22bd64b79ec078f7c86910f8d149f37f188293c48e7e0da28c06","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NBIX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:25.183687+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39:security_listing:11","subject_id":"alpha:company:b894711d-0f08-49a3-a78d-c0c6b83a1f39","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"NBIX (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"NBIX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:41.912201+00:00","sources":[{"id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:1bbcc460e570b418258090baa536a1c1a4f869fbcd9e5e616398e6b33c2dcada","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/neurocrine-biosciences-inc","source_date":null,"retrieved_at":"2026-10-16T13:51:41.912201+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5dffd2c2610c166b260bac13113faa44af6f6529f1534a4b0cbcc3fc20eac5fc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neurocrine Biosciences DEF 14A 2026-04-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000015/nbix-20260415.htm","source_date":"2026-04-15","retrieved_at":"2026-07-12T04:22:07.189599+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bc1c0c8597fdff1a389c6903401eb29f3c3cb5809ad992a2d47c31c3f64128de","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NBIX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:25.738673+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:08045820d08e0f27b7dcebc1c1632a91587349bf4d19fc15d2dff5066d4e04e0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NBIX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:24.63779+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:06787e97408e22bd64b79ec078f7c86910f8d149f37f188293c48e7e0da28c06","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NBIX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-04T23:54:25.183687+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.826,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.675,"cross_source_agreement":0.75,"temporal_completeness":1},"diagnostics":{"published_claims":10,"factual_claims":10,"claims_with_linked_evidence":10,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":5,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:51:41.912201+00:00","observed_at":"2026-10-16T13:51:41.912201+00:00","reviewed_at":"2026-10-16T13:51:41.912201+00:00","verified_at":"2026-10-16T13:51:41.912201+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":10,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/neurocrine-biosciences-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/neurocrine-biosciences-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}